Literature DB >> 22974737

Metabolism of xenobiotics of human environments.

Edward Croom.   

Abstract

Xenobiotics have been defined as chemicals to which an organism is exposed that are extrinsic to the normal metabolism of that organism. Without metabolism, many xenobiotics would reach toxic concentrations. Most metabolic activity inside the cell requires energy, cofactors, and enzymes in order to occur. Xenobiotic-metabolizing enzymes can be divided into phase I, phase II, and transporter enzymes. Lipophilic xenobiotics are often first metabolized by phase I enzymes, which function to make xenobiotics more polar and provide sites for conjugation reactions. Phase II enzymes are conjugating enzymes and can directly interact with xenobiotics but more commonly interact with metabolites produced by phase I enzymes. Through both passive and active transport, these more polar metabolites are eliminated. Most xenobiotics are cleared through multiple enzymes and pathways. The relationship between chemical concentrations, enzyme affinity and quantity, and cofactor availability often determine which metabolic reactions dominate in a given individual.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22974737     DOI: 10.1016/B978-0-12-415813-9.00003-9

Source DB:  PubMed          Journal:  Prog Mol Biol Transl Sci        ISSN: 1877-1173            Impact factor:   3.622


  39 in total

Review 1.  Altered Transport and Metabolism of Phenolic Compounds in Obesity and Diabetes: Implications for Functional Food Development and Assessment.

Authors:  Benjamin W Redan; Kimberly K Buhman; Janet A Novotny; Mario G Ferruzzi
Journal:  Adv Nutr       Date:  2016-11-15       Impact factor: 8.701

Review 2.  Scaffold-hopping as a strategy to address metabolic liabilities of aromatic compounds.

Authors:  Phillip R Lazzara; Terry W Moore
Journal:  RSC Med Chem       Date:  2019-12-16

Review 3.  Bioactive polyphenols and cardiovascular disease: chemical antagonists, pharmacological agents or xenobiotics that drive an adaptive response?

Authors:  Katarzyna Goszcz; Garry G Duthie; Derek Stewart; Stephen J Leslie; Ian L Megson
Journal:  Br J Pharmacol       Date:  2017-02-02       Impact factor: 8.739

4.  Epigenome modulated xenobiotic detoxification pathways control DMBA-induced breast cancer in agouti Avy/a mice.

Authors:  Simbarashe Mazambani; Madeleine Morris; Venugopalan Cheriyath
Journal:  Epigenetics       Date:  2019-05-09       Impact factor: 4.528

5.  Evidence of ochratoxin A conjugates in urine samples from infants and adults.

Authors:  K Muñoz; B Cramer; J Dopstadt; H-U Humpf; G H Degen
Journal:  Mycotoxin Res       Date:  2016-11-09       Impact factor: 3.833

6.  Protective effect of aerobic exercise on the vocal folds against cigarette smoke exposure.

Authors:  Ceren Ersoz Unlu; Özlem Akkoca; Ilkan Tatar; Mustafa Fevzi Sargon; Dilara Zeybek; Serpil Oguztuzun
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-04-12       Impact factor: 2.503

Review 7.  The role of cytochromes P450 in the metabolism of selected antidepressants and anxiolytics under psychological stress.

Authors:  Nina Zemanova; Pavel Anzenbacher; Eva Anzenbacherova
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2022-04-12       Impact factor: 1.245

8.  Expression, purification, and characterization of mouse glycine N-acyltransferase in Escherichia coli.

Authors:  Daniel R Dempsey; Jason D Bond; Anne-Marie Carpenter; Santiago Rodriguez Ospina; David J Merkler
Journal:  Protein Expr Purif       Date:  2014-02-25       Impact factor: 1.650

9.  Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling.

Authors:  Marie Stiborova
Journal:  J Vis Exp       Date:  2018-03-20       Impact factor: 1.355

10.  Sequence Polymorphism in Xenobiotic Metabolising Genes in Iraqi Colorectal Cancer Patients.

Authors:  Salih Q Ibrahem; Zana T Al-Dalawi; Assma S Bahaaldin
Journal:  Asian Pac J Cancer Prev       Date:  2021-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.